Your browser doesn't support javascript.
loading
Endocrine organs of cardiovascular diseases: Gut microbiota.
Jia, Qiujin; Xie, Yingyu; Lu, Chunmiao; Zhang, Ao; Lu, Yanmin; Lv, Shichao; Zhang, Junping.
Afiliación
  • Jia Q; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Xie Y; Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Lu C; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Zhang A; Epidemiology, College of Global Public Health, New York University, New York, New York.
  • Lu Y; Tianjin Nankai Hospital, Tianjin, China.
  • Lv S; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Zhang J; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
J Cell Mol Med ; 23(4): 2314-2323, 2019 04.
Article en En | MEDLINE | ID: mdl-30688023
Gut microbiota (GM) is a collection of bacteria, fungi, archaea, viruses and protozoa, etc. They inhabit human intestines and play an essential role in human health and disease. Close information exchange between the intestinal microbes and the host performs a vital role in digestion, immune defence, nervous system regulation, especially metabolism, maintaining a delicate balance between itself and the human host. Studies have shown that the composition of GM and its metabolites are firmly related to the occurrence of various diseases. More and more researchers have demonstrated that the intestinal microbiota is a virtual 'organ' with endocrine function and the bioactive metabolites produced by it can affect the physiological role of the host. With deepening researches in recent years, clinical data indicated that the GM has a significant effect on the occurrence and development of cardiovascular diseases (CVD). This article systematically elaborated the relationship between metabolites of GM and its effects, the relationship between intestinal dysbacteriosis and cardiovascular risk factors, coronary heart disease, myocardial infarction, heart failure and hypertension and the possible pathogenic mechanisms. Regulating the GM is supposed to be a potential new therapeutic target for CVD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Disbiosis / Microbioma Gastrointestinal / Intestinos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Disbiosis / Microbioma Gastrointestinal / Intestinos Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido